GenScript Expands Peptide and Oligonucleotide Manufacturing Facility in China


The spread. Oligonucleotide synthesis ability It offers qPCR oligos, NGS oligos, RNA oligos, DNA oligos and more to support a wide range of applications – from molecular diagnostics, RNA, to genome editing. Using high-throughput, large-scale synthesizers, HPLC+ and PAGE+ purification procedures for stringent contamination control, as well as ISO 13485 certification, GenScript offers up to 95% quality from ug to kg of up to 200nt DNA and 180nt RNA oligonucleotides. Purity to meet different application needs.

Similarly, it has been offering GenScript using its proprietary, microwave-assisted PepPower™ peptide synthesis platform. High quality custom peptides and peptide libraries 100% guaranteed volume at industry-leading speed – up to 5 days faster – helps accelerate research projects. With this expansion, four new flexible axial compression columns have been added to the larger peptides, with an average monthly production capacity of over 5 kg and 32 square feet. Freeze dryers to support bulk freeze-drying process. The newly expanded production lines enable GenScript to deliver up to 30,000 peptides per month and batch production at the kilogram level. GenScript is fully committed to supporting peptide researchers from peptide drug and vaccine development to functional testing and neoantigen discovery.

“GenScript’s new site in Zhengjiang is designed to provide unparalleled support and address the growing need for oligonucleotide and peptide synthesis – such as molecular diagnostics, RNA and peptide drug development, vaccine development, gene editing with faster, more reliable and more cost-effective solutions at multiple scales.” Through our modern platforms,” ​​said Dr. Ray ChenPresident of the Life Sciences Group at GenScript.

Where to learn more

About GeneScript Biotech Corporation

GenScript Biotech Corporation (HK.1548) is a leading global technology and life science R&D and manufacturing services provider. Built on its robust gene integration technology, GenScript Biotech is divided into four major platforms: Life Science Services and Products Platform, Biologics Contract Development and Manufacturing Organization (CDMO) Platform, Industrial Synthetic Products Platform and Integrated Global Cell Therapy. platform.

GenScript Biotech was founded in New JerseyIn the year In 2002, they were listed on the US and Hong Kong stock exchanges in 2015. GenScript Biotech’s business operations are in more than 100 countries and regions worldwide with legal entities located in the US, Mainland China; Hong Kong, China, Japan, Singapore, Netherlands, Irelandof united kingdomKorea and Belgium. GenScript Biotech provides premium, convenient and reliable services and products to more than 200,000 customers.

as a December 31, 2022GenScript Biotech has more than 6,000 employees worldwide, more than 37% of whom hold a Master’s and/or Ph.D. Degrees. In addition, GeneScript Biotech owns a number of intellectual property rights, including more than 210 patents, more than 800 pending patent applications and numerous trade secrets.

Guided by the corporate mission of “making people and nature healthy through biotechnology”, GenScript Biotech strives to be the world’s most trusted biotech company. as a December 31, 2022, 76,000 peer-reviewed journal articles worldwide have cited GenScript Biotech’s services and products. For more information, please visit Genscript Biotech official website.

Media Contacts:
Tim Cox
ZingPR for GenScript
[email protected]

Kay Chung
Head of Marketing, Regent Services
GenScript America Inc.
[email protected]

Source GenScript Biotech Corporation


We offer you some site tools and assistance to get the best result in daily life by taking advantage of simple experiences